Management of diastolic heart failure

Cardiology Journal

Volumn 17, Issue 6, 2010, Pages 558-565

  Kazik, Anna ^a   Wilczek, Krzysztof ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diastolic heart failure; Ejection fraction; Impaired relaxation; Left ventricular compliance

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; CHLORTALIDONE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; MORPHINE; NEBIVOLOL; NITRATE; OXYGEN; PERINDOPRIL; PLACEBO; SPIRONOLACTONE; VALSARTAN; VERAPAMIL;

AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC HEART FAILURE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG CHOICE; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LUNG EDEMA; MORTALITY; OBESITY; OXYGEN THERAPY; PROGNOSIS; RISK REDUCTION; SEX; SINUS RHYTHM; SYSTOLIC HEART FAILURE; SYSTOLIC HYPERTENSION; VENOUS PRESSURE;

CARDIOVASCULAR AGENTS; DIASTOLE; DRUG THERAPY, COMBINATION; HEART FAILURE, DIASTOLIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 78951469260     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dickstein K, Cohen-Solal A, Fillippatos G et al. ECS Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J, 2008; 29: 2388-2442.
2. Paulus W, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Association of the European Society of Cardiology. Eur Heart J, 2007; 28: 2539-2550.
3. Qwan TE, Hodge DO, Herges RM et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med, 2006; 355: 251-259.
4. Van Heerebeek L, Borbly A, Niessen HW et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation, 2006; 113: 774-781.
5. Opolski G eds. Kardiologia. 1st Ed. Urban & Partner, Wrocław 2003.
6. Nagueh SF, Appleton CP, Gillebert TC et al. Recommendations for the evaluations of left ventricular diastolic function by echocardiography. Eur J Echocardiogr, 2009; 10: 165-193.
7. Aurigemma GP. Diastolic heart failure: A common and lethal condition by any name. N Engl J Med, 2006; 355: 308-310.
8. Jessup M, Abraham WT, Casey DE et al. ACCF/AHA guidelines for the diagnosis and management of heart failure in the adult: A report of the American College of Cardiology Foundation/ /American Heart Association Task Force on Practice Guidelines. Circulation, 2009; 119: 1977-2016.
9. Gandhi SK, Powers JC, Nomeir AM et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med, 2001; 344: 17-22.
10. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal ventricular ejection fraction. Am J Cardiol, 1993; 71: 602-604.
11. Warner JG, Metzger DC, Kitzman DW et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol, 1999; 33: 1567-1572.
12. Dahlof B, Devereux RB, Kjedsen SE et al. Cardiovascular morbidity and mortality in the Losartan intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet, 2002; 359: 995-1003.
13. Yusuf S, Pfeffer MA, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: The CHARM-Preserved Trial. Lancet, 2003; 362: 771-781.
14. Cleland JGF, Tendera M, Adamus J et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J, 2006; 27: 2338-2345.
15. Solomon SD, Janardhanan R, Verma A et al.; for the Valsartan in Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. Lancet, 2007; 369: 2079-2087.
16. Kostis JB, Davis BR, Cutler J et al. Prevention on heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA, 1997; 278: 212-216.
17. Ofili EO, Cohen JD, St. Vrain J et al. Effect of treatment of isolated systolic hypertension on left ventricular mass. JAMA, 1998; 279: 778-780.
18. Bergstrom A, Adersson B, Edner M et al. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler--echocardiographic study (SWEDIC). Eur J Heart Fail, 2004; 6: 453-461.
19. Tendera M, Schneeweiss A, Bartoszewski A et al. The acute response of left ventricular filling dynamics to intravenous verapamil predicts the changes in exercise tolerance after oral verapamil therapy in patients with hypertrophic cardiomyopathy. Eur Heart J, 1993; 14: 410-415.
20. Ghio S, Magrini G, Serio A et al. SENIORS investigators. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: Results of the SENIORS echocardiographic substudy. Eur Heart J, 2006; 27: 562-568.
21. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med, 1997; 336: 325-533.
22. Kramer K, Kirkman P, Kitzman D et al. Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J, 2000; 40: 451-455.
23. Zile MR. Treating diastolic heart failure with statins: "Phat" chance for pleiotropic benefits. Circulation, 2005; 112: 300-303.
24. Fukuda H, Sane D, Brucks S et al. Statin therapy may be associated with lower mortality in patients with diastolic heart failure. A preliminary report. Circulation, 2005; 112: 357-363.
25. Chang SA, Kim YJ, Lee HW et al. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy. Hypertension, 2009; 54: 591-597.